Performance assessment of a fully automated electro-chemiluminescence immunoassay system for serum S100B protein
The altered expression levels of S100 proteins can lead to four different categories of diseases: diseases
of the heart and of the central nervous system, inflammatory disorders and cancer. Various studies have
shown the lack of harmonization of the results obtained with different methods, mainly due to different
performances and measurements of S100B. The purpose of this work was to compare quantitatively
the fully automated Elecsys® immunoassay with the reference immunoenzimatic method CanAg® EIA